Mechanistic Study of Subclinical Hypothyroidism In the Elderly

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Subclinical Hypothyroidism
Interventions
DRUG

Levothyroxine

Oral levothyroxine with a total starting dose of 0.7mcg/kg/day split into three daily doses will be titrated to a target TSH level of 0.5 -1.5mU/L

DRUG

Liothyronine

Oral liothyronine with a starting dose of 1/3 of the weight-based LT4 dose divided into three daily doses titrated to a target TSH level of 0.5 -1.5mU/L

DRUG

Thyrotropin-Releasing Hormone

200 µg intravenous TRH will be given at study visit 1 (baseline), study visit 2 (on first thyroid treatment), and study visit 3 (on second thyroid treatment).

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Pennsylvania

OTHER

NCT02399475 - Mechanistic Study of Subclinical Hypothyroidism In the Elderly | Biotech Hunter | Biotech Hunter